Navigation Links
Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease
Date:1/19/2010

St. Jude Children's Research Hospital scientists lead effort that identifies a novel way statins protect cells from a host of bacterial toxins

MEMPHIS, Tenn., Jan. 19 /PRNewswire-USNewswire/ -- New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.

Research led by St. Jude Children's Research Hospital investigators reported that drugs called statins employ several methods to dampen inflammation and block pneumococcus and certain other bacteria from infecting cells and spreading throughout the body. Elaine Tuomanen, M.D., St. Jude Infectious Diseases chair, said those methods include a newly identified mechanism that statins use to protect healthy cells by blocking the toxicity of an entire class of bacteria. Along with pneumococcus, that class includes diphtheria, tetanus, listeria and group A streptococcus, which is also known as the flesh-eating bacterium.

Tuomanen is co-senior author of the study with Carlos Orihuela, Ph.D., University of Texas Health Science Center at San Antonio (UTHSCSA). The work is published in the January 19 advanced, online edition of The Journal of Clinical Investigation.

The results provide the foundation for a possible future study to determine if statins, already widely used to lower cholesterol in adults, might protect children with sickle cell disease (SCD) from serious pneumococcal infection. SCD is an inherited blood disorder. The findings also suggest statins might protect others at high risk for pneumonia due to chronic inflammation of
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD
2. Cholesterol-lowering medicines may be effective against cancer
3. Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
4. Cholesterol-lowering drugs may also lower PSA, but whether they cut cancer risk is still not known
5. Discoverers of Small Regulatory RNAs and Cholesterol-Lowering Drugs to Receive Lasker Awards for Medical Research
6. Study shows cholesterol-lowering power of dietitian visits
7. Cholesterol-Lowering Statins Tied to Tendon Woes
8. Cholesterol-Lowering Drugs May Ease Irregular Heartbeat
9. New Type of Cholesterol-Lowering Drug Shows Promise
10. Many Patients Stop Taking Cholesterol-Lowering Drugs
11. Cholesterol-lowering drug linked to sleep disruptions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Los Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... entry featured by the Huffington Post on August 25th, writer Akela Stanfield detailed ... bariatric surgery. While the author acknowledged that she had always seen herself as someone ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... swamped with a large stream of mixed documents that include EOBs, payments, and ... documents, while extracting the data needed to reconcile their billing, with one efficient ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Sciences clinical and academic partnership has earned international recognition as a premier center ... disorder that can cause sudden, catastrophic internal bleeding and stroke. , Cure ...
(Date:9/2/2015)... ... September 02, 2015 , ... Medical ... has completed a recapitalization with new investment partners Beecken Petty O’Keefe & ... each offer extensive expertise and connections within the healthcare industry, which makes ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Amada Senior Care, ... office in Kansas – its Johnson County location. Amada franchise partners Mike ... has a registered nurse background and spent over 20 years in medical device sales ...
Breaking Medicine News(10 mins):Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:Amada Senior Care Expands to Greater Kansas City 2
... Healthcare,Corporation (Nasdaq: UAHC ), which owns and ... organization in,Tennessee, today announced financial results for its ... increased 82 percent to $8.3 million for the ... revenues of $4.6 million for,the third quarter of ...
... MOUNTAIN VIEW, Calif., May 13 IRIDEX,Corporation (Nasdaq: IRIX ... ended March 29, 2008., Revenue for the first quarter ... million reported for the first quarter of 2007. The,Company,s net ... the,first quarter of 2008 compared with a net loss of ...
... for, Potential 2008 Launch of MOXATAG; Keflex Product Sales Total $2.4 ... ... GERMANTOWN, Md., May 13 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ... today,announced financial and operational results for the quarter ended March 31,2008., ...
... that treat the poor from improving, study finds , , TUESDAY, ... hospitals that treat poor and underserved patients, often called safety-net ... these patients, a new study finds. , These hospitals, which ... sources, do not have the money to improve the quality ...
... to treat a rare but well-known genetic disorder may hold ... potentially lethal enlarged hearts, due mainly to high blood pressure, ... common denominator in both phenylketonuria (PKU) and cardiac hypertrophy is ... helps break down the molecule phenylalanine whose buildup is toxic ...
... BLOOMFIELD HILLS, Mich., May 13 CJPS Enterprises, ... be holding a,half-day mini-seminar and interactive discussions about ... to increase their,competitiveness, and therefore their worth. This ... June 6th, 2008 and is applicable to both ...
Cached Medicine News:Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 6Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 7Health News:IRIDEX Reports First Quarter 2008 Financial Results 2Health News:IRIDEX Reports First Quarter 2008 Financial Results 3Health News:IRIDEX Reports First Quarter 2008 Financial Results 4Health News:IRIDEX Reports First Quarter 2008 Financial Results 5Health News:IRIDEX Reports First Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 3Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 4Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 5Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 7Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 8Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 9Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 10Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 11Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 12Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 13Health News:Quality Lags at Safety-Net Hospitals 2Health News:Quality Lags at Safety-Net Hospitals 3Health News:Drug therapy for PKU reverses heart damage 2Health News:Drug therapy for PKU reverses heart damage 3Health News:Drug therapy for PKU reverses heart damage 4Health News:Intellectual Property Buildup Seminar to be Held in Detroit 2
(Date:9/2/2015)... YORK , Sept. 2, 2015  The report ... future market of breast cancer drugs on the basis ... cancer usually originates from the inner lining of milk ... is a malignant type of tumor that can spread ... of cancer which starts in lobules is referred as ...
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... Forecasts Summary Advanced dressings have steadily ... treatment of a variety of wound indications, such ... fluid management, infection control, and physical protection become ... a greater role in standard therapy. This ...
(Date:9/2/2015)... STAAR Surgical Company (NASDAQ: STAA ), a leading developer, ... the eye, today announced that its Board of Directors has ... Mr. Wall was formerly the General Counsel ... firm, for more than nine years. Mr. Wall is currently ... the Corporate Governance Committee and member of the Audit Committee, ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2William P. Wall Appointed to STAAR Surgical Board of Directors 2
... CVS/pharmacy introduced an updated mobile app that allows ... eliminating the need to carry an ExtraCare card when shopping. ... program with more than 69 million active cardholders, and the ... simply scan the barcode on the back of their card ...
... 1, 2012  Techne Corporation,s (NASDAQ: TECH ) ... ended March 31, 2012 include the following highlights: ... per diluted share.  Adjusted earnings for the quarter were ... of 5.9% from the same prior-year period. Adjusted earnings ...
Cached Medicine Technology:CVS/pharmacy Mobile App Transforms Smartphones into Digital ExtraCare Cards 2Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 2Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 3Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 4Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 5Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 6Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 7Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 8Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 9Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 10Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 11
... technology is here! LTF™ (Layered Thin Film) ... test platform that is easy to read, ... as a credit card. What is Infectious ... reason women visit their physician. Vaginal discharge ...
... test! QuickScreen multi-panel dip cards offer minimal ... choice of any conceivable combination of 9 ... for your drug testing program. Just dip ... built-in timer tells you when to read ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
Medicine Products: